LAT Research

Executive Summary

LAT Research is a contract research organization (CRO) based in Buenos Aires, Argentina, specializing in preclinical and clinical trial services for rare diseases. Founded in 2009, the company leverages Argentina's cost-competitive environment and skilled workforce to offer efficient trial execution for pharmaceutical and biotechnology clients. With a focused employee base of 10-50, LAT Research has built expertise in rare disease indications, positioning itself as a niche player in the Latin American CRO market. While the company remains private and relatively small, its specialization and regional foothold provide a foundation for growth as global pharma seeks to diversify trial locations and reduce costs. The rare disease focus aligns with increasing regulatory incentives and orphan drug development trends. However, competition from larger global CROs and limited scale present challenges. Overall, LAT Research represents a promising but speculative opportunity in the CRO space, with potential for steady expansion if it secures strategic partnerships or expands its service offerings.

Upcoming Catalysts (preview)

• Q3 2026Major Pharmaceutical Partnership50% success
• Q4 2026Expansion into Brazil or Mexico Markets40% success
• TBDISO 27001 or GCP Certification70% success